Back to Journals » Drug Design, Development and Therapy » Volume 12

Peptides derived from Plasmodium falciparum leucine-rich repeat 1 bind to serine/threonine phosphatase type 1 and inhibit parasite growth in vitro

Authors Pierrot C, Zhang X, Zanghi G, Fréville A, Rebollo A, Khalife J

Received 3 October 2017

Accepted for publication 8 November 2017

Published 9 January 2018 Volume 2018:12 Pages 85—88

DOI https://doi.org/10.2147/DDDT.S153095

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Professor Manfred Ogris


Christine Pierrot,1 Xiguang Zhang,2 Gigliola Zhangi,2 Aline Fréville,1 Angelita Rebollo,2 Jamal Khalife1

1Center for Infection and Immunity of Lille, U1019 – UMR 8204, Institut Pasteur de Lille, Université de Lille, Lille Cedex, 2CIMI Paris, UPMC/Inserm U1135, Paris, France
 
The biogenesis of protein phosphatase 1 (PP1) holoenzyme in eukaryotes requires diverse regulatory subunit proteins (RSPs) that bind to the highly conserved PP1 catalytic subunit (PP1c) and direct its spatiotemporal activity as well as its specificity. Several studies demonstrated that most RSPs share a canonical common binding motif, the RVXF motif, which is present in ~85% of RSPs and is considered as the main contributor for the interaction to PP1c.1 In Plasmodium falciparum (Pf), our earlier studies revealed that leucine-rich repeat 1 (LRR1), one of the major RSPs of PfPP1 and an ortholog of human and yeast Sds22, lacks the RVXF motif. The amino acids sequence of PfLRR1 exhibits nine leucine-rich repeats (LRRs) and a hydrophobic region at the C-terminal end, known as the LRR cap motif.2 In this work, we identified the PP1-binding peptides of PfLRR1 and examined their capacity to affect Pf growth. 
Corrigendum for this paper has been published 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under a Creative Commons Attribution License. The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/. The license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Download Article [PDF]  View Full Text [HTML][Machine readable]